Japanese CROs Seek Partnerships Abroad To Survive
This article was originally published in PharmAsia News
Executive Summary
Japanese clinical trial companies are seeking affiliations with similar firms abroad to survive in what has become a highly competitive business. Some Japanese firms, such as Asklep, consider international cooperation as part of an effort by companies in many countries to obtain business beyond their own borders. Among Japanese firms joining forces with others are Asklep, with Qualitix Clinical Research of Taiwan, and with ties to German and Canadian firms, and Acronet, joined with another Taiwanese company that already has entry into the United States and Asian markets. (Click here for more - a subscription may be required
|
Japanese clinical trial companies are seeking affiliations with similar firms abroad to survive in what has become a highly competitive business. Some Japanese firms, such as Asklep, consider international cooperation as part of an effort by companies in many countries to obtain business beyond their own borders. Among Japanese firms joining forces with others are Asklep, with Qualitix Clinical Research of Taiwan, and with ties to German and Canadian firms, and Acronet, joined with another Taiwanese company that already has entry into the United States and Asian markets. (Click here for more - a subscription may be required) "Clinical Test Firms Grow Expertise, Foreign Alliances" - Nikkei (Japan) (10/23/08) |